Loading organizations...
Key people at ClimateCrop - photosynthesis enhancement.
ClimateCrop is an agricultural technology company based in Rehovot, Israel, that develops advanced genetic solutions to enhance photosynthesis in crops and improve overall plant efficiency. The organization targets fundamental limitations in plant biology to boost agricultural productivity sustainably, allowing crops to harness more solar energy and significantly increase their yield potential. These biological enhancements are primarily designed for the broader agriculture sector, serving farmers and commercial growers seeking to maximize crop outputs without expanding their physical land footprint or increasing chemical fertilizer usage. Operating with a specialized research team of fewer than 15 employees, the enterprise has successfully garnered early-stage financial backing from notable venture capital firms, including SOSV, IndieBio, and Jerusalem Venture Partners. ClimateCrop was officially established in 2021 by founder Yehuda Borenstein to directly address escalating global food security and supply chain challenges.
Key people at ClimateCrop - photosynthesis enhancement.
# ClimateCrop: Photosynthesis Enhancement Through Gene Editing
ClimateCrop is an agricultural biotechnology company that uses non-GMO gene editing to enhance photosynthetic efficiency in plants, enabling higher yields and greater climate resilience without requiring farmers to change their practices.[1][2] Founded in 2021 and based in Ness Ziona, Israel, the company addresses a critical global challenge: meeting surging demand for essential crops while adapting to climate volatility and resource constraints.[2][3]
The company's core offering targets a fundamental inefficiency in nature—photosynthesis itself wastes significant sunlight energy.[7] By increasing starch storage in plant leaves through a precise genetic modification, ClimateCrop enables plants to capture and utilize more solar energy, translating into measurable improvements in yield, drought tolerance, and heat resilience.[2][3] The technology applies broadly across food, animal feed, fiber, and fuel industries, with potential applications across 391,000 vascular plant species.[3]
ClimateCrop emerged from a chance encounter between entrepreneurs and plant scientists. Co-founder Yehuda was approached by another entrepreneur interested in licensing plant biotechnology from Israel's Weizmann Institute.[2] This led to a lunch meeting with Erez and Vivek, researchers who had previously developed the underlying technology at Weizmann.[2] Though Yehuda initially lacked deep plant biology expertise, the founding team gained critical early validation by being accepted into IndieBio (SOSV), an accelerator specializing in biotech and climate ventures.[2]
A pivotal discovery reshaped their direction: what the team initially believed was an improvement in starch production revealed itself to be something far more significant—a genuine enhancement in photosynthetic efficiency.[2] This realization, described as the "Holy Grail" for plant growers, became the foundation for ClimateCrop's technology and business model.[2] The company has since raised $280K and operates at the convertible note stage.[1]
The technology relies on downregulating a single enzyme to increase transitory starch biosynthesis in leaves.[7] This simplicity contrasts sharply with more complex approaches to photosynthesis enhancement, reducing implementation risk and regulatory complexity.[5]
ClimateCrop uses precise gene editing rather than genetic modification, a distinction that carries regulatory and market advantages in regions with strict GMO restrictions.[1][2][3]
Unlike many agricultural innovations, the technology requires no new machinery, mechanization, or operational changes—farmers continue existing practices while capturing yield improvements.[2][3] This dramatically accelerates adoption potential.
Early research conducted at Weizmann showed a 15% increase in photosynthesis efficiency in unoptimized settings.[5] Press releases reference dramatic yield improvements, including a 90% yield increase in potato trials.[6]
The energy metabolism pathway targeted by ClimateCrop exists across all vascular plants, enabling the same core technology to upgrade crops for diverse end-uses—from staple foods to industrial materials and biofuels.[3][7]
ClimateCrop operates at the intersection of three converging imperatives: climate adaptation, food security, and sustainable agriculture. Global crop yields face mounting pressure from heat waves, drought, and resource depletion, while demand for agricultural output continues rising.[2][6] Traditional breeding and agronomic improvements have plateaued in many crops, creating space for biotechnological solutions.
The company's timing aligns with growing institutional acceptance of gene editing technologies (particularly CRISPR-adjacent approaches) and increased venture capital focus on climate-tech and agri-biotech.[6] Strategic investors like UM6P Ventures—the investment arm of Morocco's OCP and UM6P university—signal recognition that crop enhancement technologies are critical infrastructure for African and global food security.[6]
ClimateCrop's approach also sidesteps the regulatory and consumer acceptance challenges that have constrained GMO adoption in many markets, positioning it to scale in regions where genetic modification remains controversial. By improving photosynthetic efficiency rather than introducing foreign genes, the company offers a pathway to yield gains that feels more aligned with "natural" plant optimization.
ClimateCrop is pursuing a high-impact, low-complexity solution to a fundamental agricultural bottleneck. The company's next phase involves scaling from laboratory validation to field-ready prototypes and securing partnerships with major crop producers.[2][6] UM6P Ventures' investment included commitments to provide greenhouse facilities and support market expansion into the United States, with an initial subsidiary planned for Research Triangle Park, North Carolina.[6]
The critical inflection points ahead are regulatory approval pathways (which vary significantly by crop and geography) and securing commercial partnerships with seed companies or agricultural input providers. If the 15% photosynthesis efficiency gains hold across diverse crop varieties and growing conditions, ClimateCrop could reshape global agricultural productivity without requiring farmers to abandon existing infrastructure—a rare combination in agri-biotech. The company's influence will ultimately depend on whether early laboratory results translate to consistent, economically viable field performance at scale.
